We also revealed a unique mechanism by which LAMR1 restricts ZIKV infection through attenuating E protein ubiquitination, which suggests that E protein ubiquitination may be a suitable target for the design of drugs to treat ZIKV infection. The gene discussed is RPSA; the disease is Zika virus infectious disease.